| Net earnings (loss) | -37M |
| Loss on sale of discontinued operations, net of tax | |
| Impairment charges | |
| Loss on early extinguishment of debt | |
| Depreciation and amortization | 64M |
| Stock-based compensation expense | 9M |
| Reorganization items, net | |
| Changes in estimates related to expected allowable claims | |
| Contractual post-petition interest expense | |
| Equity income | |
| Accounts receivable | -7M |
| Inventories | -11M |
| Restricted cash | |
| Accounts payable | 5M |
| Pension and post-retirement health care liabilities | -57M |
| Liabilities subject to compromise | |
| Other | -18M |
| Net cash used in operating activities | 87M |
| Net proceeds from divestments | 0 |
| Payments for acquisitions | |
| Capital expenditures | -62M |
| Net cash used in investing activities | -62M |
| CASH FLOWS FROM FINANCING ACTIVITIES | |
| Proceeds from Amended DIP Credit Facility | |
| Payments on DIP Credit Facility | |
| Proceeds from short term borrowings, net | |
| Payments for debt issuance and refinancing costs | |
| Proceeds from exercise of stock options | 0 |
| Net cash provided by financing activities | -151M |
| Effect of exchange rates on cash and cash equivalents | 5M |
| Change in cash and cash equivalents | -121M |
| Cash and cash equivalents at beginning of period | |
| Cash and cash equivalents at end of period | |
| CASH FLOWS FROM FINANCING ACTIVITIES | |
| Proceeds from Credit Facility, net | |
| CASH FLOWS FROM FINANCING ACTIVITIES | |
| Proceeds from Credit Facility, net | |